Molecular Cancer Therapeutics

Published by: American Association for Cancer Research  

People

  1. Rosen
    Rosen
  2. Blasberg
    Blasberg
  3. Zanzonico
    Zanzonico
  4. Cheal
    Cheal
  5. Cheung
    Cheung
  6. Chiosis
    Chiosis
  7. Guo
    Guo
  8. Solit
    Solit
  9. Xu
    Xu
  10. Cercek Hanjis
    Cercek Hanjis

Groups

  1. GSK Faculty (12)
  2. Molecular Pharmacology and Chemistry Program Faculty (12)
  3. Sloan Kettering Institute Faculty (12)
  4. Department of Medicine (8)
  5. Sloan Kettering Institute Postdocs (8)
  6. Solid Tumor Oncology Division (8)
  7. Breast Medicine Service (5)
  8. Surgery (5)
  9. Center for Molecular Imaging and Biotechnology (4)
  10. Molecular Imaging and Therapy Service (4)
Search Within
  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (4)
Groups
  1. GSK Faculty (12)
  2. Molecular Pharmacology and Chemistry Program Faculty (12)
  3. Sloan Kettering Institute Faculty (12)
  4. Department of Medicine (8)
  5. Sloan Kettering Institute Postdocs (8)
  6. Solid Tumor Oncology Division (8)

More Groups

People
  1. Neal Rosen (4)
  2. Pat Zanzonico (3)
  3. Ronald Blasberg (3)
  4. Steven Larson (3)
  5. David Solit (2)
  6. Gabriela Chiosis (2)

More People

Years
  1. 2022 (1)
  2. 2019 (2)
  3. 2017 (1)
  4. 2014 (1)
  5. 2010 (1)
  6. 2008 (1)

More Years

Publishers
  1. American Association for Cancer Research (12)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intraperitoneal pretargeted radioimmunotherapy for colorectal peritoneal carcinomatosis
    Journal Article

    Chandler, C. S.; Bell, M. M.; Chung, S. K.; Veach, D. R.; Fung, E. K.; Punzalan, B.; Burnes Vargas, D.; Patel, M.; Xu, H.; Guo, H. F.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • eIF4A regulates ERK activation by controlling the translation of DUSP6
    Meeting Abstract

    Xu, J.; Wendel, H. G.; Pelletier, J.; Yao, Z.; Rosen, N.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Inhibition of Hsp90 suppresses PI3K/AKT/mTOR signaling and has antitumor activity in Burkitt lymphoma
    Journal Article

    Giulino-Roth, L.; van Besien, H. J.; Dalton, T.; Totonchy, J. E.; Rodina, A.; Taldone, T.; Bolaender, A.; Erdjument-Bromage, H.; Sadek, J.; Chadburn, A.; more...
    Molecular Cancer Therapeutics (2017)

    Fulltext@MSK | Save
  • Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex
    Journal Article

    Cheal, S. M.; Xu, H.; Guo, H. F. ; Zanzonico, P. B.; Larson, S. M.; Cheung, N. K.
    Molecular Cancer Therapeutics (2014)

    Fulltext@MSK | Save
  • Genetically engineered oncolytic newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma
    Journal Article

    Silberhumer, G. R.; Brader, P.; Wong, J.; Serganova, I. S.; Gonen, M.; González, S. J.; Blasberg, R.; Zamarin, D.; Fong, Y.
    Molecular Cancer Therapeutics (2010)

    Fulltext@MSK | Save
  • HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells
    Journal Article

    Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C. T.; Tang, L.; Song, L.; Zeng, Z.; Shah, M.; Christensen, J. G.; Rosen, N.; Solit, D. B.; more...
    Molecular Cancer Therapeutics (2008)

    Fulltext@MSK | Save
  • BRAF mutation predicts MEK-dependence in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Pratilas, C. A.; Halilovic, E.; Persaud, Y.; Sawai, A.; Grbovic-Huezo, O.; Janakiraman, M.; Rosen, N.; Solit, D. B.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Circulating tumor cells as prognostic biomarkers in patients with metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Heller, G.; Leversha, M. A.; Lilja, H.; Gonzalez-Espinoza, R.; Anand, A.; Larson, S.; Schwartz, L. H.; Fleisher, M.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model
    Journal Article

    Brader, P.; Riedl, C. C.; Woo, Y.; Ponomarev, V.; Zanzonico, P.; Wen, B.; Cai, S.; Hricak, H.; Fong, Y.; Blasberg, R.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save

    • Molecular Cancer Therapeutics – authorized name for:

    Name ISSN / ISBN Publisher
    Molecular Cancer Therapeutics 15388514 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15388514 American Association for Cancer Research
    Molecular cancer therapeutics 15388514 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 Unknown
    Molecular Cancer Therapeutics 15357163 The Authors the American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 Unknown
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research